Cargando…
Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes: A meta-analysis
OBJECTIVE: Both in vitro and in vivo studies indicate that metformin inhibits cancer cell growth and reduces cancer risk. Recent epidemiological studies suggest that metformin therapy may reduce the risks of cancer and overall cancer mortality among patients with type 2 diabetes. However, data on it...
Autores principales: | Zhang, Zhi-Jiang, Zheng, Zhi-Jie, Kan, Haidong, Song, Yiqing, Cui, Wei, Zhao, Genming, Kip, Kevin E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177711/ https://www.ncbi.nlm.nih.gov/pubmed/21949223 http://dx.doi.org/10.2337/dc11-0512 |
Ejemplares similares
-
Is the Combination of Sulfonylureas and Metformin Associated With an Increased Risk of Cardiovascular Disease or All-Cause Mortality?: A meta-analysis of observational studies
por: Rao, Ajay D., et al.
Publicado: (2008) -
Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency
por: Lipska, Kasia J., et al.
Publicado: (2011) -
Metformin for Obesity in Children and Adolescents: A Systematic Review
por: Park, Min Hae, et al.
Publicado: (2009) -
Cognitive Function in Children With Type 1 Diabetes: A meta-analysis
por: Gaudieri, Patricia A., et al.
Publicado: (2008) -
Depression and Type 2 Diabetes Over the Lifespan: A meta-analysis
por: Mezuk, Briana, et al.
Publicado: (2008)